Rest in peace, Keegan Peterson Jeremy Berke, Yeji Jesse Lee Marijuana plants grow near a road in the Rif region, near Chefchaouen, Morocco, August 11, 2008.
Welcome to Insider Cannabis, our weekly newsletter where we re bringing you an inside look at the deals, trends, and personalities driving the multibillion-dollar global cannabis boom.
Hello,
Before we dive in this week, I wanted to alert you all to the tragic passing of Keegan Peterson last Thursday, at the age of 33.
As many of you who read this newsletter know, Keegan was the CEO of the Denver-based Wurk, a prominent member of the broader cannabis industry and community, and a mainstay on the conference circuit.
Vireo Health Hires Victor Mancebo From Liberty Health Sciences
Science-focused cannabis company Vireo Health International Inc. (CSE:VREO)(OTCQX:VREOF) welcomed Victor E. Mancebo to its Board of Directors.
Mancebo’s duties on the board will include advising Chairman and CEO Dr. Kyle Kingsley and also the company’s executive leadership team.
Prior to joining Vireo’s Board, Mancebo was appointed as the President and CEO of another cannabis company,
Liberty Health Sciences (CSE:LHS) (OTCQX:LHSIF), which runs 29 dispensaries and a 250,000 sq. ft. manufacturing facility in Florida. To Vireo, he brings almost 20 years of experience in various leadership roles, covering retail, agricultural, and operational sectors.
Cannabis producers
Tilray (NASDAQ:TLRY) rocked the industry when they announced last month that they were merging to create the largest cannabis company in the world (based on pro forma revenue). The move instantly creates a new leading cannabis company in Canada, and one that could become a big competitor in the U.S. market once pot is legal at the federal level.
For a long time, many cannabis investors saw
Canopy Growth (NASDAQ:CGC) as the industry leader. But with the company struggling to generate sales growth, there are much better pot stocks to buy. And the deal with Aphria and Tilray only makes matters worse, as it creates a powerhouse that s a much better bargain than Canopy Growth.
At the same time, Canada is experiencing growth from the derivatives market as cannabis 2.0 begins to make traction in the latter part of the year. Besides that, the U.N. has deemed cannabis as a medicinal drug and removed cannabis from the dangerous drug schedule it was before. Currently, Mexico is in the process of becoming one of the worldâs largest additions to the cannabis market. This is due to an upcoming vote that will legalize recreational use throughout the country. All signs in 2020 point to the possibility of growth for the cannabis industry in many aspects.Are Pot Stocks A Good Investment For 2021?